Literature DB >> 3135159

Immunologic aspects of cystic fibrosis.

G Döring1, A Albus, N Høiby.   

Abstract

Bacterial infections determine life expectancy in the hereditary disease cystic fibrosis (CF). The dominant pathogens are Staphylococcus aureus and Pseudomonas aeruginosa, which persist in the patient's respiratory tract. Current explanations of the chronicity of the infections in the apparently immunocompetent host are based on defective opsonophagocytosis. This may be caused by (1) bacterial exopolysaccharide production, leading to cryptic infection types; (2) cleavage of immunoglobulin, complement, and surface receptors on immunocompetent cells by host proteases; and (3) a change from opsonic to nonopsonic antibody isotypes. Continuous antigenic stimulation of the immune system leads to local immune complex formation and a high chronic hypersensitivity reaction as well as to temporary immune unresponsiveness. Progressive tissue damage caused by lysosomal enzymes and oxygen radicals from polymorphonuclear leukocytes is thought to be ultimately responsible for respiratory failure and death in CF. Besides antibiotic treatment, anti-inflammatory therapy is therefore currently considered beneficial.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135159     DOI: 10.1378/chest.94.2_supplement.109s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  Pulmonary defence mechanisms: damage and repair. Opportunities for intervention.

Authors:  E F Weltevreden
Journal:  Pharm Weekbl Sci       Date:  1989-08-25

Review 2.  Role of free radicals in the pathogenesis of cystic fibrosis.

Authors:  R K Brown; F J Kelly
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

3.  Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.

Authors:  T R Anderson; T C Montie; M D Murphy; V P McCarthy
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

4.  Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by Pseudomonas aeruginosa.

Authors:  K Weiss; J R Lapointe
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

5.  Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis.

Authors:  C Francoeur; M Denis
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092

6.  Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis.

Authors:  R G Cowan; G B Winnie
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

7.  Neutrophil-derived Oxidants and Proteinases as Immunomodulatory Mediators in Inflammation.

Authors:  V Witko-Sarsat; B Descamps-Latscha
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.